Alvarez E O, Banzan A M
Laboratorio de Investigaciones Cerebrales (LINCE-CONICET), Facultad de Ciencias Médicas, U.N.C., Mendoza, Argentina.
Brain Res Bull. 1987 Aug;19(2):165-73. doi: 10.1016/0361-9230(87)90082-7.
The effect of histamine (HA), 3-methyl-histamine (3MHA), HA antagonists or drugs interfering with HA synthesis, microinjected into the hippocampus (HPC), on prolactin (PRL) secretion were studied in rats. Three experiments were performed. In Experiment 1, increasing doses of HA or 3-MHA (9-90 nmol) were microinjected stereotaxically into the ventral HPC of adult male rats. In Experiment 2, 135 nmol of pyrilamine (PYR, an H1-HA-antagonist) or ranitidine (RAN, an H2-HA-antagonist) were administered locally into the ventral HPC. Fifteen min later, the rats were microinjected again with 45 nmol of HA. In Experiment 3, rats were microinjected with different doses of HA-antagonists or with 20 nmol of alpha-fluormethyl-histidine (FMH, an inhibitor of the enzyme of HA synthesis) and later subjected to an immobilization stress of 15 min duration. In all cases, the PRL plasma concentrations were measured in blood samples taken at different time intervals (0-120 min) after the last brain injection. Results showed that HA applied locally in ventral HPC induced an increase in PRL levels which was statistically significant from saline-injected rats between 5-30 min after the HPC stimulation. On the contrary, local applications of 3-MHA did not change significantly the PRL blood levels (Experiment 1). Only PYR did block partially the PRL response due to HA in basal conditions. RAN in these later conditions had no effect (Experiment 2). When animals were subjected to stress neither PYR nor RAN, alone or in combination, locally applied were able to block the PRL increase due to stress. Only FMH blunted significantly the hormone response.(ABSTRACT TRUNCATED AT 250 WORDS)
研究了向大鼠海马体(HPC)中微量注射组胺(HA)、3 - 甲基组胺(3MHA)、HA拮抗剂或干扰HA合成的药物对催乳素(PRL)分泌的影响。进行了三个实验。实验1中,将递增剂量的HA或3 - MHA(9 - 90纳摩尔)立体定向微量注射到成年雄性大鼠的腹侧HPC。实验2中,将135纳摩尔的吡拉明(PYR,一种H1 - HA拮抗剂)或雷尼替丁(RAN,一种H2 - HA拮抗剂)局部注射到腹侧HPC。15分钟后,再次给大鼠微量注射45纳摩尔的HA。实验3中,给大鼠微量注射不同剂量的HA拮抗剂或20纳摩尔的α - 氟甲基组氨酸(FMH,一种HA合成酶抑制剂),随后使其遭受持续15分钟的固定应激。在所有情况下,在最后一次脑内注射后的不同时间间隔(0 - 120分钟)采集血样,测量血浆PRL浓度。结果显示,在HPC刺激后5 - 30分钟,局部应用于腹侧HPC的HA导致PRL水平升高,与注射生理盐水的大鼠相比具有统计学显著性。相反,局部应用3 - MHA并未显著改变PRL血液水平(实验1)。在基础条件下,只有PYR能部分阻断HA引起的PRL反应。在此条件下,RAN无作用(实验2)。当动物受到应激时,局部单独或联合应用PYR和RAN均不能阻断应激引起的PRL升高。只有FMH能显著减弱激素反应。(摘要截短至250字)